Revvity Board Declares Quarterly Dividend

WALTHAM, Mass.--(BUSINESS WIRE)-- The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 7, 2026 to all shareholders of record at the close of business on July 17, 2026.

About Revvity

At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2025 revenue of $2.9 billion and approximately 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 160 countries.

Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260430973813/en/

Media Relations:
Chet Murray
(781) 462-5126
[email protected]

Investor Relations:
Steve Willoughby
[email protected]

Source: Revvity

You May Also Be Interested In

• BlackRock MuniAssets Fund, Inc. (MUA) Announces Results of its Over-Subscribed Rights Offering
• Best Crypto To Buy Now: Hyperliquid Hits Record $106M Fees as Pipedog Rally Sends Meme Hunters Toward AlphaPepe
• Faraday Future Presents at the 2026 J.P. Morgan Conference in New York; Investors Show Strong Interest in FF's EAI Robotics Strategy